I guess it was too much to hope that the great run would continue, and this week was one of the worst ever weeks, with most of last week's gains being wiped out as OPTI:Optibiotix fell 8p. It was a pretty rotten week across most of the portfolio, with few shares finishing the week better off. The deficit between cost and value widened by £18,397 to £79,289 and total portfolio value dropped to £107,696.
The worst performer was ANTO:Antofagasta, which zoomed upwards early in the week until the day I did my monthly savings transaction, after which it absolutely plummeted leaving me having purchased at the top of the spike. The impact was a 12% drop in value, and I went from being 11% up to 1% down. Just about summed up the week!
RIO:Rio Tinto also struggled, dropping 5% despite announcing lots of exciting new ventures.
The biggest disaster was OPTI:Optibiotix dropping 8p. For my cheapest shares that was a drop of 83%, and even for my most expensive shares it was a drop of 9%.
There was some consolation for some of my other larger holdings, with CAML:Central Asia Metals up 5% after being tipped in a Sunday paper. That was enough to put one of my holdings 2% into profit.
PBX:Probiotix Health climbed 1p, which is 5% for my big dividend holding, and 13% for my more recent cheaper buys.
Share of the Week is SBTX:SkinBioTherapeutics which climbed 11% and begged the question whether people were selling OPTI to buy SBTX?
Here's the ISA and shares portfolio after week 2 of year 9.
| Weekly Change | |||
| Cash | £153.80 | -£109.89 | |
| Portfolio cost | £88,364.43 | +£509.89 | |
| Portfolio sell value (bid price-commission) | £48,157.05 | (-45.5%) | -£8,417.81 |
| Potential profits | £2,912.18 | -£2,018.58 | |
| Yr 9 Dividends | £0 | +£0 | |
| Yr 9 Interest | £0 | +£0 | |
| Yr 9 Profit from sales | £0 | +£0 | |
| Yr 9 proj avg monthly profit | -£8.15 | (-0.2%) | +£8.13 |
| Total Dividends | £11,911.43 | +£0 | |
| Total Interest | £1.93 | +£0 | |
| Total Profit from sales | £17,298.53 | +£0 | |
| Average monthly cash profit | £298.87 | (6.0%) | -£0.72 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 48% | +0% |
I found £400 down the back of various account's sofas and added it to my ISA along with £100 of dividends transferred from my AJ Bell dealing account. That gave me £500 to buy some more shares. I bought 7,143 shares in JLP:Jubilee Metals at 6.999p costing £509.89 as I think they are ridiculously under priced. That brings the average for my AJ Bell holding down to 7.414p and increases my holding there to 26,703, and my total JLP holding now stands at 143,725. They are losing £5,168 at the moment so a turnaround would have a significant improvement on my overall performance.
The rest of the story is misery as half my potential OPTI:Optibiotix profits are wiped out along with £8,417 portfolio value.
I guess it's not a surprise, but I was hoping for consolidation rather than a big drop.
Still reassuringly high above the trend line which will hopefully flatten out soon.
My monthly savings investment was with ANTO:Antofagasta where I bought 14 shares at 1638.67p costing £232.06 with commission and stamp duty. They immediately fell to 1509p, which I consider a disaster of bad timing. The rest of the story mirrors that of the ISA thanks to the big drop in OPTI:Optibiotix.
It was nice to be above the injection for a short time.
The trend line might be flat by next week unless we plummet again.
I guess it's not a surprise, but I was hoping for consolidation rather than a big drop.
Still reassuringly high above the trend line which will hopefully flatten out soon.
The SIPP looks like this after week 402 overall and week 38 of year 8.
| Weekly Change | ||||
| Cash | £152.31 | -£232.06 | ||
| Portfolio cost | £96,247.60 | +£232.06 | ||
| Portfolio sell value (bid price - commission) | £57,842.70 | (-39.9%) | -£9,951.22 | |
| Potential profits | £4,250.67 | -£3,094.23 | ||
| Yr 8 Dividends | £239.37 | +£0 | ||
| Yr 8 Interest | £3.82 | +£0 | ||
| Yr 8 Profit from sales | -£9,597.85 | +£0 | ||
| Yr 8 proj avg monthly profit | -£1,078.79 | (-19.8%) | +£29.15 | |
| Total Dividends | £14,382.15 | +£0 | ||
| Total Interest | £4.07 | +£0 | ||
| Total Profit from sales | £10,835.90 | +£0 | ||
| Average monthly cash profit | £260.00 | (4.8%) | -£0.65 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 37% | +0% |
My monthly savings investment was with ANTO:Antofagasta where I bought 14 shares at 1638.67p costing £232.06 with commission and stamp duty. They immediately fell to 1509p, which I consider a disaster of bad timing. The rest of the story mirrors that of the ISA thanks to the big drop in OPTI:Optibiotix.
It was nice to be above the injection for a short time.
The trend line might be flat by next week unless we plummet again.
The trading account looks like this after week 368 overall and week 4 of year 8.
Everything dropped this week, so we're back to a familiar pattern for the trading account. My genius purchase of BARC:Barclays has been underwhelming, with them dropping 12% in a few weeks, and my two purchases of JLP:Jubileee Metals are down by 48%. At least I have £273 cash, which I'm half tempted to take out to get the injection line down, but the prospect of only needing £230 profit to enable an additional share to be bought means I'll leave it alone.
I guess that doesn't look too bad compared the the recent past
Right on the trend line, which means we have to go up next week to avoid dipping below it.
| Weekly Change | |||
| Cash | £273.24 | +£0 | |
| Portfolio cost | £1,794.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,117.76 | (-37.7%) | -£28.47 |
| Potential profits | £0 | +£0 | |
| Year 8 Dividends | £0 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £283.99 | +£0 | |
| Yr 8 proj avg monthly profit | £307.65 | (+205.7%) | -£102.55 |
| Dividends | £60.10 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£646.70 | +£0 | |
| Average monthly cash profit | -£6.91 | (-4.6%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
Everything dropped this week, so we're back to a familiar pattern for the trading account. My genius purchase of BARC:Barclays has been underwhelming, with them dropping 12% in a few weeks, and my two purchases of JLP:Jubileee Metals are down by 48%. At least I have £273 cash, which I'm half tempted to take out to get the injection line down, but the prospect of only needing £230 profit to enable an additional share to be bought means I'll leave it alone.
I guess that doesn't look too bad compared the the recent past
Right on the trend line, which means we have to go up next week to avoid dipping below it.
OPTI:Optibiotix was bound to drift if there was no news, but I was really hoping there would be news. If none is forthcoming next week there's a risk we'll drift the same amount again and all my optimism would have been a very short-lived spike. The key to maintaining my morale is not to drop more than £7k, as that will take my portfolio value back below £100k and I'll be very sad.
No comments:
Post a Comment